Viewing Study NCT02404220


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-02-24 @ 4:46 PM
Study NCT ID: NCT02404220
Status: TERMINATED
Last Update Posted: 2020-01-02
First Post: 2015-03-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Syk inhibitor View
None Blood malignancy View
None Leukemia View